The abstract is read at the publisher; the summary is JClub's.
Siglec-15, a DAP12-signaling immune receptor, is linked to protumorigenic tumor-associated macrophage (TAM) reprogramming, characterized by interleukin-10 and transforming growth factor-β production.
- Why it matters: Understanding Siglec-15’s glycan ligands is critical because it connects tumor-associated glycosylation to immune suppression in the tumor microenvironment (TME) and informs therapeutic targeting.
- What they did: The receptor signals via DAP12 and can bind both N-linked and O-linked sialoglycans, with glycan sulfation enhancing binding; ligand specificity depends on glycan display on scaffolds including CD44 and CD11b.
- The result: Evidence from multiple studies links Siglec-15 expression in cancers to negative correlation with programmed cell death protein 1/programmed death-ligand 1, and blocking antibodies show promising (pre)clinical effects.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.